Product Information
DILTIAZEM 120 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0990 per EA under NDC 00093032101. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on May 31, 1995. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
120 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093032101
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DILTIAZEM HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA074185FDA Approved
5/31/1995
TE Code
AB
On Market Since
12/26/1995
Pharmacological Classes
Price Statistics
The NADAC for DILTIAZEM 120 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 45.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0990 per EA |
|---|---|
| All-time high | $0.3819 (Dec 16, 2015) |
| All-time low | $0.0935 (Dec 17, 2025) |
| 52-week high | $0.1088 |
| 52-week low | $0.0935 |
| Median price | $0.3048 |
| Average price | $0.2746 |
| Largest weekly change | +38.6% (Feb 21, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Diltiazem Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Calcium Channel Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DILTIAZEM 120 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DILTIAZEM 120 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.0990 per EA (NDC 00093032101), effective Sep 30, 2026.
How has the price of DILTIAZEM 120 MG TABLET changed over time?
Over the history we have for it, the NADAC for DILTIAZEM 120 MG TABLET has declined 45.5%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DILTIAZEM 120 MG TABLET?
Since Nov 28, 2013, the NADAC for DILTIAZEM 120 MG TABLET has ranged from a low of $0.0935 (Dec 17, 2025) to a high of $0.3819 (Dec 16, 2015), with a median of $0.3048 per EA.
Are there cheaper alternatives to DILTIAZEM 120 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DILTIAZEM 120 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures DILTIAZEM 120 MG TABLET?
DILTIAZEM 120 MG TABLET (NDC 00093032101) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.